Transit Scientific
-
FDA Clears Balloon Dilation Scoring and Constraining Platform to Treat Small or Distal Peripheral Vasculature
Transformative Angioplasty Sheath Platform Compatible with a Broad Range of Off-the-Shelf PTA and PTCA Angioplasty Balloons Cleared by…
-
Jennifer Arnold, COO of Transit Scientific, promoted to President & CEO
Jennifer Arnold, COO of Transit Scientific, promoted to President & CEO
-
Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA
Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA
-
Medical Technology Company Focused on Vessel Preparation, Dilation, And Treatment Delivery Secures Series B Funding
Medical Technology Company Focused on Vessel Preparation, Dilation, And Treatment Delivery Secures Series B Funding
-
U.S. Patent Office Grants New Patent Protection For Exoskeleton Focal-Force Angioplasty Platform
Transit Scientific achieved increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology using standard off-the-shelf peripheral…
-
FDA Clears Four New Coronary Micro Support Catheters
Non-tapered metal-alloy support catheter platform receives FDA clearance for use in coronary and peripheral vasculature.
-
Transit Scientific’s New Scoring Sheath Delivers Low Pressure Angioplasty Treatment in Calcified Arteries
First-of-its kind metal-alloy angioplasty scoring sheath effective in treatment of critical arterial stenosis
-
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
-
FDA Clears 12 New XO Cross Microcatheters
12 new hydrophilic-coated micro and support catheters cleared by FDA for broad use in the peripheral vasculature.
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
